Corline Biomedical AB Net Asset Quality Index
Corline Biomedical AB net asset quality index. Corline Biomedical AB (CLBIO) has a Net Asset Quality Index of 86.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr114.18 Million minus total liabilities of Skr15.18 Million yields net assets of Skr99.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check CLBIO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Corline Biomedical AB (2012–2025)
Net asset quality index of Corline Biomedical AB from 2012 to 2025. This chart shows how Corline Biomedical AB's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the index stands at 86.7%, representing net assets of Skr99.00 Million against total assets of Skr114.18 Million SEK. See CLBIO book value for net asset value and shareholders' equity analysis.
Corline Biomedical AB Net Asset Quality Index by Year (2012–2025)
Corline Biomedical AB net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Corline Biomedical AB from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CLBIO market cap overview.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | Skr93.76 Million | Skr98.58 Million | Skr4.82 Million | ▲ +3.4 pp |
| 2024 | 91.7% | Skr86.91 Million | Skr94.76 Million | Skr7.85 Million | ▼ -1.5 pp |
| 2023 | 93.2% | Skr93.32 Million | Skr100.11 Million | Skr6.79 Million | ▲ +0.3 pp |
| 2022 | 92.9% | Skr94.59 Million | Skr101.78 Million | Skr7.19 Million | ▲ +2.2 pp |
| 2021 | 90.7% | Skr92.23 Million | Skr101.66 Million | Skr9.43 Million | ▲ +1.5 pp |
| 2020 | 89.3% | Skr52.03 Million | Skr58.28 Million | Skr6.25 Million | ▼ -3.8 pp |
| 2019 | 93.0% | Skr59.32 Million | Skr63.75 Million | Skr4.43 Million | ▲ +5.7 pp |
| 2018 | 87.4% | Skr54.96 Million | Skr62.91 Million | Skr7.95 Million | ▼ -1.9 pp |
| 2017 | 89.3% | Skr45.93 Million | Skr51.43 Million | Skr5.50 Million | ▼ -4.6 pp |
| 2016 | 93.9% | Skr38.75 Million | Skr41.27 Million | Skr2.53 Million | ▲ +8.9 pp |
| 2015 | 85.0% | Skr21.25 Million | Skr24.99 Million | Skr3.74 Million | ▲ +52.3 pp |
| 2014 | 32.7% | Skr5.48 Million | Skr16.77 Million | Skr11.29 Million | ▼ -25.4 pp |
| 2013 | 58.1% | Skr8.00 Million | Skr13.76 Million | Skr5.76 Million | ▲ +47.1 pp |
| 2012 | 11.0% | Skr1.37 Million | Skr12.46 Million | Skr11.09 Million | — |